Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

15,277 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Denosumab-induced hypocalcemia in patients with solid tumors and renal dysfunction: a multicenter, retrospective, observational study.
Nakamura K, Kaya M, Yanagisawa Y, Yamamoto K, Takayashiki N, Ukita H, Nagura M, Sugiue K, Kitajima M, Hirano K, Ishida H, Onoda C, Kobayashi Y, Nakatani E, Odagiri K, Suzuki T. Nakamura K, et al. Among authors: yamamoto k. BMC Cancer. 2024 Feb 15;24(1):218. doi: 10.1186/s12885-024-11942-2. BMC Cancer. 2024. PMID: 38360579 Free PMC article.
Chemotherapy-induced neutropenia as a prognostic factor in patients with extensive-stage small cell lung cancer.
Miyagi T, Tsuji D, Kawasakai Y, Ishikawa H, Tanaka R, Nakao M, Nakagaki S, Hayashi T, Ayuhara H, Harada T, Tamaki S, Maeda A, Ohashi Y, Arakawa Y, Fujita Y, Yamamoto K, Miyamoto Y, Yano T, Itoh K. Miyagi T, et al. Among authors: yamamoto k. Eur J Clin Pharmacol. 2023 Mar;79(3):407-414. doi: 10.1007/s00228-023-03451-1. Epub 2023 Jan 16. Eur J Clin Pharmacol. 2023. PMID: 36645467
A multicenter phase II trial of the triplet antiemetic therapy with palonosetron, aprepitant, and olanzapine for a cisplatin-containing regimen. - PATROL-I.
Tsuji D, Nakagaki S, Yonezawa I, Suzuki K, Yokokawa T, Kawasaki Y, Yamaguchi T, Kawaguchi T, Hatori M, Matsumoto T, Sakata Y, Yamamoto K, Nishimura T, Kogure Y, Hayashi T, Osawa M, Itoh K, Watanabe M. Tsuji D, et al. Among authors: yamamoto k. Invest New Drugs. 2024 Feb;42(1):44-52. doi: 10.1007/s10637-023-01414-y. Epub 2023 Dec 6. Invest New Drugs. 2024. PMID: 38055127 Clinical Trial.
Long-read sequencing for 29 immune cell subsets reveals disease-linked isoforms.
Inamo J, Suzuki A, Ueda MT, Yamaguchi K, Nishida H, Suzuki K, Kaneko Y, Takeuchi T, Hatano H, Ishigaki K, Ishihama Y, Yamamoto K, Kochi Y. Inamo J, et al. Among authors: yamamoto k. Nat Commun. 2024 May 28;15(1):4285. doi: 10.1038/s41467-024-48615-4. Nat Commun. 2024. PMID: 38806455 Free PMC article.
15,277 results
You have reached the last available page of results. Please see the User Guide for more information.